Metagenomics Market 2022 Research Report, Upcoming Trends, Demand, Regional Analysis and Forecast 2027

IMARC Group's latest report, titled "Metagenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global metagenomics market size reached US$ 452.9 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 875 Million by 2027, exhibiting a growth rate (CAGR) of 11.41% during 2022-2027.

Metagenomics is the study of microbial genomes in a natural environment or community as a whole. It comprises cloning of genome in order to study diversity, ecology, and evolution in an effective manner and bypasses the need for laboratory cultivation or isolation of individual species. It utilizes bioinformatics and sequencing technologies for acquiring scientific insights, which is further used as a molecular tool for analyzing the deoxyribonucleic acid (DNA) attained from environmental samples, including the soil, human waste, and water. These samples are further processed through gene prediction, sequence reading, and functional annotation to diagnose environmental remediation, infectious diseases, development of biofuels, and gut microbe characterization. Some of the products used in metagenomics include kits and reagents and sequencing and data analytics services.

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players being

• Agilent Technologies Inc
• Enterome
• Eurofins Scientific
• F. Hoffmann-La Roche AG (Roche Holding AG)
• Illumina Inc
• Novogene Co. Ltd
• Oxford Nanopore Technologies Limited
• Pacific Biosciences of California Inc
• PerkinElmer Inc
• QIAGEN N.V
• Swift Biosciences Inc. (Danaher Corporation)
• Thermo Fisher Scientific Inc

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/metagenomics-market/requestsample

Metagenomics Market Growth:

The escalating demand for metagenomics from researchers majorly drives the global market. This can be attributed to the increasing prevalence of virus-induced infections, including influenza, HIV/AIDS, and hepatitis B among the masses. Coupled with this, the accelerating need for effective solutions to timely diagnose neuroinfectious diseases, such as encephalitis and meningitis, is also significantly supporting the market. Additionally, the widespread adoption of metagenomics to identify the bacterial pathogen that causes foodborne diseases is providing a boost to the demand. Moreover, the widespread integration of next-generation sequencing services with data analysis software for faster sample processing and data analysis is creating a positive market outlook. Some of the other factors driving the market include continual technological advancements in the biotechnology field and extensive research and development (R&D) activities in the field of life sciences.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/metagenomics-market

Key Market Segmentation:

Breakup by Product:

• Instruments and Software
• Consumables

Breakup by Technology:

• Sequencing
• Bioinformatics

Breakup by Application:

• Infectious Disease Diagnosis
• Environmental Remediation
• Gut Microbe Characterization
• Biotechnology
• Biofuel
• Agriculture

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Research Reports:

• https://www.imarcgroup.com/warehouse-robotics-market
• https://www.imarcgroup.com/optical-coherence-tomography-market
• https://www.imarcgroup.com/protein-expression-market
• https://www.imarcgroup.com/medical-device-outsourcing-market
• https://www.imarcgroup.com/smart-grid-market

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.